Stonebridge Capital Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-17
| Closed | -$14K | – | 703 |
|
|
2023
Q3 | $14K | Hold |
17
| – | – | ﹤0.01% | 550 |
|
|
2023
Q2 | $12.2K | Hold |
17
| – | – | ﹤0.01% | 587 |
|
|
2023
Q1 | $14K | Buy |
17
+5
| +42% | +$4.11K | ﹤0.01% | 562 |
|
|
2022
Q4 | $8.66K | Buy |
12
+2
| +20% | +$1.44K | ﹤0.01% | 621 |
|
|
2022
Q3 | $7K | Hold |
10
| – | – | ﹤0.01% | 644 |
|
|
2022
Q2 | $6K | Hold |
10
| – | – | ﹤0.01% | 693 |
|
|
2022
Q1 | $7K | Sell |
10
-2
| -17% | -$1.4K | ﹤0.01% | 729 |
|
|
2021
Q4 | $8K | Hold |
12
| – | – | ﹤0.01% | 679 |
|
|
2021
Q3 | $7K | Sell |
12
-3
| -20% | -$1.75K | ﹤0.01% | 679 |
|
|
2021
Q2 | $8K | Buy |
15
+10
| +200% | +$5.33K | ﹤0.01% | 775 |
|
|
2021
Q1 | $2K | Buy |
+5
| New | +$2K | ﹤0.01% | 854 |
|